About Pathozyme Diagnostics
Pathozyme Diagnostics is a Healthcare company. Manufacturing and marketing of diagnostic reagents and medical devices in the healthcare sector. The company has 2 employees. Its Indian entity Oxalis Diagnostics Private Limited reported revenue of ₹5.86 Cr. Pathozyme Diagnostics offers products and services including Clinical Chemistry Reagents and Serology Reagents. Its focus areas include Medical Devices, Diagnostics, Reagents Manufacturing and Biotechnology.
Company details
Pathozyme Diagnostics is recognized as a leading provider of healthcare solutions, having been established in 2006 to focus on the innovation and development of medical devices and reagents. It is noted for manufacturing clinical chemistry, serology, and protein immunoassay reagents that adhere to international standards through rigorous quality assurance protocols. Commitments to RD, process validation, and certifications like ISO 9001:2015 and ISO 13485:2016 are maintained to enhance quality of life and reduce human suffering. Participation in external quality assurance programs ensures customer satisfaction, while a positive work environment is fostered for employees.
- Employees 2
- SectorsHealthcare
- Email••••••••
- Legal Name Oxalis Diagnostics Pvt. Ltd
- Date of Incorporation 22 Sep, 2016
- Jurisdiction Kolhapur, Maharashtra, India
- Indian entity revenue₹5.86 Cr
FY 2025 · +37% YoY
- Indian entity net profit₹34.4 Lakh
FY 2025 · 6% margin
- Indian entity EBITDA₹75.5 Lakh
FY 2025 · 13% margin
- Employee Count2
Associated legal entities of Pathozyme Diagnostics
Pathozyme Diagnostics operates through Oxalis Diagnostics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Oxalis Diagnostics Private Limited CIN U51900PN2016PTC166529 | Active | 22 Sep 2016 | Kolhapur, Maharashtra | ₹5.9 Cr | 2 | 2 | View details |
Products & Services of Pathozyme Diagnostics
Pathozyme Diagnostics offers a comprehensive portfolio of products and services, including Clinical Chemistry Reagents and Serology Reagents.
Clinical chemistry reagents are manufactured for diagnostic laboratories, ensuring they perform according to international standards.
Serology reagents are developed for various immunoassay applications, contributing to improved healthcare outcomes.
Board of directors of Oxalis Diagnostics Private Limited (Pathozyme Diagnostics)
Oxalis Diagnostics Private Limited is the primary company behind Pathozyme Diagnostics. The board of Oxalis Diagnostics Private Limited currently have 2 directors; the longest-serving is Virshri Mahadev Patil, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Virshri Mahadev Patil DIN 07555126 | Director | 22 Sep 2016 | 10 yrs | Oxalis Diagnostics Private Limited |
| Mahadev Pandurang Patil DIN 06685410 | Director | 22 Sep 2016 | 10 yrs | Oxalis Diagnostics Private Limited |
Financials of Pathozyme Diagnostics
Figures of Oxalis Diagnostics Private Limited, the primary company behind Pathozyme Diagnostics, for FY 2025. Revenue was ₹5.86 Cr (+37% year on year). Net profit was ₹34.4 Lakh (6% margin). EBITDA was ₹75.5 Lakh (13% margin). Revenue has grown at a compounded annual rate of +31% over three years and +61% over five years.
- ₹5.86 CrRevenue · FY 2025 · +37% YoY
- ₹34.4 LakhNet profit · 6% margin
- ₹75.5 LakhEBITDA · 13% margin
- ₹1 LakhPaid-up capital
- 2Employees (provident fund records)
- +31%Revenue CAGR, 3 years
- +61%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Oxalis Diagnostics Private Limited are on its company page.
Detailed financial statements for Pathozyme Diagnostics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pathozyme Diagnostics
Pathozyme Diagnostics has 2 employees.
The primary company behind Pathozyme Diagnostics, Oxalis Diagnostics Private Limited, reported revenue of ₹5.86 Cr for FY 2025, up 37% year on year.
Pathozyme Diagnostics is recognized as a leading provider of healthcare solutions, having been established in 2006 to focus on the innovation and development of medical devices and reagents. It is noted for manufacturing clinical chemistry, serology, and protein immunoassay reagents that adhere to international standards through rigorous quality assurance protocols. Commitments to RD, process validation, and certifications like ISO 9001:2015 and ISO 13485:2016 are maintained to enhance quality of life and reduce human suffering. Participation in external quality assurance programs ensures customer satisfaction, while a positive work environment is fostered for employees.
Pathozyme Diagnostics offers Clinical Chemistry Reagents and Serology Reagents.
Pathozyme Diagnostics operates through Oxalis Diagnostics Private Limited.
The legal entities of Pathozyme Diagnostics currently have 2 directors, including Virshri Mahadev Patil, Mahadev Pandurang Patil.